Calculates a score used to estimate the degree of liver fibrosis based on specific blood test results. The tool accepts inputs such as age, serum sodium levels, AST (aspartyl-amino transferase), ALT (alanine aminotransferase), and platelet count. By incorporating these measurable clinical values into a standardized formula, it produces an overall FIB-4 index score. This non-invasive assessment helps healthcare providers gauge the likelihood of advanced scarring in the liver without requiring additional procedures like biopsy.
Healthcare professionals, including primary care physicians and specialists, utilize this resource during routine patient evaluation. It provides an initial screening measure to help manage patients with suspected chronic liver disease. A high or low score guides further diagnostic steps, informing whether more detailed investigation is warranted.